Impact of dose interruption on the efficacy of lenvatinib in a phase 3 study in patients with radioiodine-refractory differentiated thyroid cancer
Tahara, Makoto, Brose, Marcia S., Wirth, Lori J., Suzuki, Takuya, Miyagishi, Hideaki, Fujino, Katsuki, Dutcus, Corina E., Gianoukakis, AndrewVolume:
106
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2018.10.002
Date:
January, 2019
File:
PDF, 419 KB
english, 2019